🇺🇸 FDA
Patent

US 11091518

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 11091518 (Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same) held by Inovio Pharmaceuticals, Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/55527